Abstract
Ramucirumab (Cyramza(R)), a fully human anti-VEGFR-2 monoclonal antibody, has been approved as monotherapy for the treatment of patients with hepatoce......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
